Strong Alliance to Create a New Landscape in Health
With the rising global awareness of health, the health industry is experiencing unprecedented development opportunities. According to market forecasts from the China Consumers Association’s “Health Industry Consumption Trend Development Report”, by 2025, the market size of China’s health industry is expected to reach 17.4 trillion RMB, and it is projected to climb to 29.1 trillion RMB by 2030. The functional food industry, as a vital component of the health market, is attracting increasing capital and policy support.
As a listed company on the main board of the Hong Kong Stock Exchange, Wantian’s collaboration with Hin Sang will further strengthen its presence in the health sector, paving the way for its vision to become a global leader in the full industry chain of green food services.
Focusing on Three Strategic Cooperation Areas
The cooperation will focus on three major strategic areas to expand and innovate within the functional food market:
Synergies to Create Long-Term Value
This strategic partnership represents more than just a merging of resources and technology; it brings forth substantial synergies. Wantian’s extensive experience in the green food supply chain will open up broader sales channels for Hin Sang’s products, while Hin Sang’s strong brand influence in the health sector will support Wantian’s swift entry into the functional food market. Together, their collaboration is poised to drive product innovation, optimize operational efficiency, and accelerate market expansion, leading to strong long-term returns.
As China’s “Healthy China 2030” blueprint, the health industry holds tremendous growth potential. This partnership between Wantian and Hin Sang is perfectly aligned with market trends and leverages policy incentives, setting the stage for a prosperous future in the health sector. Both companies foresee significant business outcomes from this collaboration, positioning it as a model for industry partnerships.
Wantian’s foray into the health industry underscores its keen market insights and strategic foresight. This initiative not only supports its efforts to diversify its business but also establishes a robust foundation for sustained growth. As Wantian continues to expand and innovate, it is well-positioned to become a leading player in the health market, generating lasting value and returns.Hashtag: #ChinaWantian
The issuer is solely responsible for the content of this announcement.
China Wantian Holdings Limited (1854.HK) is a listed company on the main board of the Hong Kong Stock Exchange. The company focuses on the supply of green ingredients, eco-friendly dining, and environmental technologies, striving to enhance the entire food industry’s value chain. Committed to becoming a global leader in the full industry chain of green food services, Wantian upholds a strong dedication to quality and innovation, delivering healthier and more enriching dining experiences from farm to table for households around the world.
Hin Sang Group (6893.HK) operates under the philosophy of “selecting the natural, nourishing with herbs,” focusing on the development of herbal health products. The company provides innovative and high-quality health solutions for families worldwide. Its products have received numerous industry accolades, and signature offerings like ” Hin Sang Exquisite Packing Milk Supplement” and ” Hin Sang Health Star” have achieved great market success, positioning the group as a leader in the health product industry.
HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…